Population
105 malignant hyperthermia families, including 10 central core disease families phenotyped by the in vitro…
Design
Cross-sectional
Authors
Loading...
RYR1 screening may support MH diagnosis; leaves open prospective validation before replacing IVCT in practice.
Genetic screening of RYR1 in malignant hyperthermia families identifies novel mutations and shows high concordance with the in vitro contracture test, supporting its diagnostic utility.
Agnieszka Brandt (1999) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: